跳转到主要内容
搜索

Christer Tannergren

Director, PBPK
Christer Tannergren

Before joining Certara 2026, Christer held a position as a Principal Scientist and Global Biopharmaceutics Science & Strategy Lead at AstraZeneca. Christer brings over 20 years of industry expertise in all aspects of Biopharmaceutics, drug product development and Biopharmaceutics modelling cross all stages of development as well as all major therapy areas. He received his PhD in Biopharmaceutics from Uppsala University in 2004 where he acquired expertise in the in vivo importance of intestinal permeability, transporters and gutwall metabolism. Christer has 49 peer-reviewed publications and is the inventor of one formulation patent.

Christer is passionate about applying biopharmaceutics and PBPK modelling to add value to clients and patients by enabling decision making, influencing product design and accelerating development. He has also co-organised several cross industry-regulatory agencies collaborations to progress the field of using PBPK/PBBM for regulatory drug product quality applications.

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software